These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38571468)

  • 1. Tumefactive Primary Central Nervous System Vasculitis: Dynamic Susceptibility Contrast Perfusion-Weighted Magnetic Resonance Imaging Findings With Histological Correlation.
    Muccio CF; Di Lorenzo L; Lepore G; Savarese F; Schipani S; Chiarotti I; Cerase A
    Clin Ter; 2024; 175(2):112-117. PubMed ID: 38571468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-Enhanced Magnetic Resonance Imaging, Perfusion Magnetic Resonance Imaging, and 1H-Magnetic Resonance Spectroscopy Distinguish Primary Central Nervous System Vasculitis from Glioblastoma.
    Kawazoe Y; Ohba S; Murayama K; Nakae S; Nishiyama Y; Abe M; Hasegawa M; Hirose Y
    World Neurosurg; 2022 Feb; 158():e820-e828. PubMed ID: 34813936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumefactive Primary Central Nervous System Vasculitis: Imaging Findings of a Rare and Underrecognized Neuroinflammatory Disease.
    Suthiphosuwan S; Bharatha A; Hsu CC; Lin AW; Maloney JA; Munoz DG; Palmer CA; Osborn AG
    AJNR Am J Neuroradiol; 2020 Nov; 41(11):2075-2081. PubMed ID: 32883666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of Glioblastoma and Solitary Brain Metastasis by Gradient of Relative Cerebral Blood Volume in the Peritumoral Brain Zone Derived from Dynamic Susceptibility Contrast Perfusion Magnetic Resonance Imaging.
    She D; Xing Z; Cao D
    J Comput Assist Tomogr; 2019; 43(1):13-17. PubMed ID: 30015801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved performance of non-preloaded and high flip-angle dynamic susceptibility contrast perfusion-weighted imaging sequences in the presurgical differentiation of brain lymphoma and glioblastoma.
    Wang F; Zhou X; Chen R; Kang J; Yang X; Lin J; Liu F; Cao D; Xing Z
    Eur Radiol; 2023 Dec; 33(12):8800-8808. PubMed ID: 37439934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pearls & Oy-sters: Tumour-Like Mass Lesion Secondary to Primary CNS Vasculitis.
    Roberts JI; Ng D; Kapadia R
    Neurology; 2024 Oct; 103(7):e209819. PubMed ID: 39255434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of susceptibility-weighted imaging & contrast-enhanced MRI in the diagnosis of primary CNS vasculitis: a large case series.
    Agarwal S; Sebastian LJD; Gaikwad S; Srivastava MVP; Sharma MC; Singh M; Bhatia R; Agarwal A; Sharma J; Dash D; Goyal V; Srivastava AK; Tripathi M; Suri V; Singh MB; Sarkar C; Suri A; Singh RK; Vibha D; Pandit AK; Rajan R; Gupta A; Elavarasi A; Radhakrishnan DM; Das A; Tandon V; Doddamani R; Upadhyay A; Vishnu VY; Garg A
    Sci Rep; 2024 Feb; 14(1):4718. PubMed ID: 38413676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concordance of angiography and cerebral biopsy results for suspected primary central nervous system vasculitis: A multi-center retrospective review.
    Raghavan A; Wright JM; Huang Wright C; Shammassian BH; Onyewadume L; Momotaz H; Burant CJ; Sajatovic M; Carandang R; Furlan A; Calabrese L; DeGeorgia M
    Clin Neurol Neurosurg; 2019 Oct; 185():105482. PubMed ID: 31421586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneously changing MRI findings of primary central nervous system vasculitis: A case report.
    Takatsu H; Komatsu T; Fukasawa N; Fukuda T; Iguchi Y
    J Clin Neurosci; 2021 Jan; 83():125-127. PubMed ID: 33246904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol vs. gadoteridol: a pilot study.
    Gahramanov S; Raslan AM; Muldoon LL; Hamilton BE; Rooney WD; Varallyay CG; Njus JM; Haluska M; Neuwelt EA
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):514-23. PubMed ID: 20395065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproducibility of rCBV in glioblastomas using T2*-weighted perfusion MRI: an evaluation of sampling, normalization, and experience.
    Yüzkan S; Mutlu S; Karagülle M; Şam Özdemir M; Özgül H; Arıkan MA; Koçak B
    Diagn Interv Radiol; 2024 Mar; 30(2):124-134. PubMed ID: 37789677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of dynamic susceptibility contrast-enhanced perfusion MR imaging in differentiating between infectious and neoplastic focal brain lesions: results from a cohort of 100 consecutive patients.
    Floriano VH; Torres US; Spotti AR; Ferraz-Filho JR; Tognola WA
    PLoS One; 2013; 8(12):e81509. PubMed ID: 24324699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy.
    Salvarani C; Brown RD; Calamia KT; Christianson TJ; Huston J; Meschia JF; Giannini C; Miller DV; Hunder GG
    Rheumatology (Oxford); 2008 Nov; 47(11):1671-7. PubMed ID: 18753193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR dynamic-susceptibility-contrast perfusion metrics in the presurgical discrimination of adult solitary intra-axial cerebellar tumors.
    Pons-Escoda A; Garcia-Ruiz A; Garcia-Hidalgo C; Gil-Solsona R; Naval-Baudin P; Martin-Noguerol T; Fernandez-Coello A; Flores-Casaperalta S; Fernandez-Viñas M; Gago-Ferrero P; Oleaga L; Perez-Lopez R; Majos C
    Eur Radiol; 2023 Dec; 33(12):9120-9129. PubMed ID: 37439938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiography-negative primary central nervous system vasculitis: a syndrome involving small cerebral vessels.
    Salvarani C; Brown RD; Calamia KT; Christianson TJH; Huston J; Meschia JF; Giannini C; Miller DV; Hunder GG
    Medicine (Baltimore); 2008 Sep; 87(5):264-271. PubMed ID: 18794709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
    Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral abscesses and necrotic cerebral tumours: differential diagnosis by perfusion-weighted magnetic resonance imaging.
    Muccio CF; Esposito G; Bartolini A; Cerase A
    Radiol Med; 2008 Aug; 113(5):747-57. PubMed ID: 18414811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary central nervous system vasculitis and its mimicking diseases - clinical features, outcome, comorbidities and diagnostic results - A case control study.
    Becker J; Horn PA; Keyvani K; Metz I; Wegner C; Brück W; Heinemann FM; Schwitalla JC; Berlit P; Kraemer M
    Clin Neurol Neurosurg; 2017 May; 156():48-54. PubMed ID: 28324788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permeability measurement using dynamic susceptibility contrast magnetic resonance imaging enhances differential diagnosis of primary central nervous system lymphoma from glioblastoma.
    Lee JY; Bjørnerud A; Park JE; Lee BE; Kim JH; Kim HS
    Eur Radiol; 2019 Oct; 29(10):5539-5548. PubMed ID: 30877463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions.
    Cha S; Pierce S; Knopp EA; Johnson G; Yang C; Ton A; Litt AW; Zagzag D
    AJNR Am J Neuroradiol; 2001; 22(6):1109-16. PubMed ID: 11415906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.